Edges in Network
| Network | GSE16391_top500tf - GSE16391 - SiGN-BN HC+Bootstrap |
| Network Description | GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial |
| Node | IRF2 |
| Upstream (Parents) |
|---|
| (<<) ONECUT2 → IRF2 |
| (<<) IRF7 → IRF2 |
| (<<) ZFP36L2 → IRF2 |
| (<<) TRIM22 → IRF2 |
| (<<) FLI1 → IRF2 |
| (<<) IRF9 → IRF2 |
| (<<) HCLS1 → IRF2 |
| (<<) MAX → IRF2 |
| (<<) ZNF281 → IRF2 |
| (<<) NFATC2 → IRF2 |
| Downstream (Children) |
|---|
| IRF2 → MEOX1 (>>) |
| IRF2 → BTG2 (>>) |
| IRF2 → CREB3L1 (>>) |
| IRF2 → TP53 (>>) |
| IRF2 → ZNF85 (>>) |
| IRF2 → MYCL1 (>>) |
| IRF2 → REL (>>) |
| IRF2 → IRF4 (>>) |
| IRF2 → ZNF24 (>>) |
| IRF2 → CEBPA (>>) |
| IRF2 → DRAP1 (>>) |
| IRF2 → TRIM25 (>>) |
| IRF2 → TAF5L (>>) |
| IRF2 → SOX5 (>>) |
